Trends and Characteristics of Buprenorphine-Involved Overdose Deaths Prior to and During the COVID-19 Pandemic
Authors:
- 3 January 2023
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 6 (1) , e2251856
Abstract
The overdose crisis in the US continues to escalate, likely associated with the widespread availability of highly potent synthetic opioids, such as illicitly manufactured fentanyl and fentanyl analogs (IMFs) in the illicit drug supply.1,2 Provisional data from the Centers for Disease Control and Prevention (CDC) estimate more than 107 000 overdose deaths in the US in the 12 months ending July 2022, with more than 81 000 deaths involving opioids.3 Expanding access to medications for opioid use disorder (OUD) is a central component of the US response to the overdose crisis.4Keywords
This publication has 26 references indexed in Scilit:
- Medications for Opioid Use Disorder Save Lives2019
- Non-Prescribed Buprenorphine in New York City: Motivations for Use, Practices of Diversion, and Experiences of StigmaJournal of Substance Abuse Treatment, 2016
- 2013 NCHS Urban-Rural Classification Scheme for Counties.2014
- Medication-Assisted Treatment With Buprenorphine: Assessing the EvidencePsychiatric Services, 2014
- Opioid Agonist Treatments and Heroin Overdose Deaths in Baltimore, Maryland, 1995–2009American Journal of Public Health, 2013
- Maintenance Medication for Opiate Addiction: The Foundation of RecoveryJournal of Addictive Diseases, 2012
- Oral substitution treatment of injecting opioid users for prevention of HIV infectionCochrane Database of Systematic Reviews, 2011
- Methadone maintenance therapy versus no opioid replacement therapy for opioid dependenceCochrane Database of Systematic Reviews, 2009
- Cochrane Database of Systematic ReviewsCochrane Database of Systematic Reviews, 2007
- 1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trialThe Lancet, 2003